[Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia]

Rev Med Interne. 2009 Sep;30(9):803-5. doi: 10.1016/j.revmed.2009.01.008. Epub 2009 Aug 11.
[Article in French]

Abstract

There are several possible pathophysiological links between the development of pulmonary hypertension and myelofibrosis with myeloid metaplasia. We report a woman with myelofibrosis and myeloid metaplasia who presented with dyspnea and massive, painful splenomegaly. Right heart catheterization evidenced pulmonary hypertension. Her management consisted of splenic irradiation associated to sildenafil. Dyspnea in patients with myelofibrosis and myeloid metaplasia can be secondary to pulmonary hypertension and conversely the differential diagnosis of pulmonary hypertension should include a myeloproliferative syndrome.

Publication types

  • Case Reports
  • Comparative Study
  • English Abstract

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Cardiac Catheterization
  • Diagnosis, Differential
  • Diuretics / administration & dosage
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Dyspnea / etiology*
  • Echocardiography, Doppler
  • Electrocardiography
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Furosemide / administration & dosage
  • Furosemide / therapeutic use
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Hypertension, Pulmonary / complications*
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / drug therapy
  • Middle Aged
  • Myeloproliferative Disorders / diagnosis
  • Palliative Care
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / therapeutic use
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use
  • Primary Myelofibrosis / complications*
  • Purines / administration & dosage
  • Purines / therapeutic use
  • Sildenafil Citrate
  • Splenic Diseases / complications*
  • Splenomegaly / etiology
  • Splenomegaly / radiotherapy
  • Sulfones / administration & dosage
  • Sulfones / therapeutic use
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use

Substances

  • Anticoagulants
  • Diuretics
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Furosemide
  • Sildenafil Citrate